Meng Guo
Hong Kong Baptist University(HK)
Publications by Year
Research Areas
Immune Cell Function and Interaction, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Pancreatic function and diabetes, CAR-T cell therapy research
Most-Cited Works
- → Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma(2020)165 cited
- → Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts(2012)94 cited
- → Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-β promoter regions(2017)93 cited
- → Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue(2024)82 cited
- → MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1(2017)74 cited
- → Rb selectively inhibits innate IFN-β production by enhancing deacetylation of IFN-β promoter through HDAC1 and HDAC8(2016)41 cited
- → Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer(2015)40 cited
- → Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development(2018)39 cited
- → Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models(2013)39 cited
- → SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection(2012)35 cited